My doctor recommended that i split the dosage and take 100mg in the morning/day and 50mg at evening/night.
Asked 16 Nov 2015 by alfredojr100 Updated 22 January 2020 Topics klonopin, zoloft, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, social anxiety disorder, postpartum depression, major depressive disorder, side effect, dosage. The first week and a half was AWFUL - no appetite, tummy trouble, and heightened anxiety. I was feeling awesome on 100mg before shit hit the fan. Is this the best way or should i take the full dose at the same time? In the treatment of other indications, safety and efficacy have not been established in patients younger than 1 month (prescription-only formulations) and 12 years (over-the-counter formulations).Hemodialysis: The dosing schedule should be adjusted to coincide with the end of hemodialysis.Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Detailed Ranitidine dosage information for adults and children.
informational and educational purposes only. May increase by 25 mg at 1-week intervals; not to exceed 200 mg qDayMay increase by 25 mg at 1-week intervals; not to exceed 200 mg qDayMay increase by 25 mg at 1-week intervals; not to exceed 200 mg qDayMay increase by 25 mg at 1-week intervals not to exceed 200 mg qDayInitial: 50 mg qDay PO given continuously throughout menstrual cycle or given during luteal phase onlyMay increase by 50 mg at the onset of each new menstrual cycle; no more than 150 mg qDay when administered continuously or 100 mg qDay when administered during luteal phase only25-100 mg daily for up to 5 years; 75-100 mg doses found to be most effectiveMay increase by 50 mg qDay at 1-week intervals to no more than 200 mg qDay; give qHS if somnolence experiencedThe elderly are prone to SSRI/SNRI-induced hyponatremia; monitor closely25 mg PO qDay initially; may increase by 25 mg every 2-3 days; not to exceed 200 mg qDayAlzheimer dementia related depression: Start at 12.5 mg/day and titrate every 1-2 weeks to response; not to exceed 150-200 mgMild hepatic impairment (Child-Pugh 5-6): Decrease recommended starting dose and therapeutic dose by 50%Moderate-to-severe hepatic impairment (Child-Pugh 7-15): Not recommended; sertraline is extensively metabolized, and the effects in patients with moderate and severe hepatic impairment have not been studiedIn short-term studies, antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults (<24 years) taking antidepressants for major depressive disorders and other psychiatric illnessesThis increase was not seen in patients over age 24 years; a slight decrease in suicidal thinking was seen in adults over age 65 yearsIn children and young adults, risks must be weighed against the benefits of taking antidepressantsPatients should be monitored closely for changes in behavior, clinical worsening, and suicidal tendencies; this should be done during initial 1-2 months of therapy and dosage adjustmentsThe patient’s family should communicate any abrupt changes in behavior to the healthcare providerWorsening behavior and suicidal tendencies that are not part of the presenting symptoms may require discontinuation of therapyThis drug is not approved for use in pediatric patients for major depressive disorder but it is approved for obsessive compulsive disorder in children >6 yearsNot approved for the treatment of bipolar depressionDo not use disulfiram concomitantly with oral solution due to alcohol in preparationClinical worsening and suicide ideation may occur despite medicationMay worsen mania symptoms or precipitate mania in patients with bipolar disorderIncreases risk of hyponatremia and impairment of cognitive/motor functions in the elderlyIncreases risk of bleeding in patients taking anticoagulants/antiplatelets concomitantlyRisk of mydriasis; may trigger angle closure attack in patients with angle closure glaucoma with anatomically narrow angles without a patent iridectomyPregnancy: Conflicting evidence regarding use of SSRIs during pregnancy and increased risk of persistent pulmonary hypertension of the newborn (see Pregnancy)In neonates exposed to SNRIs/SSRIs late in third trimester: Risk of complications such as feeding difficulties, irritability, and respiratory problemsBone fractures reported with antidepressant therapy; consider the possibility if patient presents with bone pain, bruising, or point of tendernessCoadministration with other drugs that enhance the effects of serotonergic neurotransmission (eg, tryptophan, fenfluramine, fentanyl, 5-HT agonists, St. John’s Wort) should be undertaken with caution and avoided whenever possible due to the potential for pharmacodynamic interaction (see Contraindications)May cause false-positive urine immunoassay screening tests for benzodiazepinesSSRIs and SNRIs are associated with development of SIADH; hyponatremia reportedUse late in the third trimester associated with complications in newborns and may require prolonged hospitalization, respiratory support, and tube feedingDistributed into milk; use caution (AAP states effect on nursing infants is unknown but may be of concern)A: Generally acceptable.